IP Library Granted Patent US 8,163,525
Granted Patent B2
US 8,163,525 · App. 12/139,175 · Granted Apr 24, 2012

Method of expressing long-chain prenyl diphosphate synthase

Assignee: Kaneka Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,525
App. No.
12/139,175
Granted
Apr 24, 2012
Kind
B2
Abstract

The present disclosure describes a method of producing a long-chain prenyl diphosphate synthase (in particular decaprenyl diphosphate synthase and solanesyl diphosphate synthase) using a gene and a protein which are required for enabling or enhancing the activity expression of a eukaryote-derived long-chain prenyl diphosphate synthase as well as a method of efficiently producing a coenzyme Q having a long-chain isoprenoid in its side chain (in particular coenzyme Q 9 or coenzyme Q 10 ) using a microorganism. The present disclosure also describes a DNA having a base sequence shown under SEQ ID NO:1, 3 or 5 and a DNA sequence derived from the above base sequence by deletion, addition, insertion and/or substitution of one to several bases thereof, and coding for a protein enabling (functioning) or enhancing the activity expression of a eukaryote-derived long-chain prenyl diphosphate synthase in a cell of a host organism.

Claims (14)

1. A transformant that is transformed with

at least one selected from the group consisting of the Schizosaccharomyces pombe DPS gene, the human DPS1 gene and the mouse SDS1 gene; and

a DNA defined under (a) or (b):

(a) a DNA encoding a protein which has the amino acid sequence of SEQ ID NO: 2;

(b) a DNA encoding a protein which has the amino acid sequence derived from the amino acid sequence of SEQ ID NO: 2 by deletion, addition, insertion or substitution of one amino acid thereof,

wherein the DNA defined under (a) or (b) enables or enhances the activity of the Schizosaccharomyces pombe DPS gene, the human DPS1 gene and/or the mouse SDS1 gene in a cell of a host organism, and

wherein the Schizosaccharomyces pombe DPS gene is amplifiable using polymerase chain reaction (PCR) primers of SEQ ID NOs: 13 and 14, the human DPS1 gene is amplifiable with PCR primers of SEQ ID NOs: 15 and 16, and the mouse SDS1 gene is amplifiable with PCR primers of SEQ ID NOs: 17 and 18.

2. The transformant according to claim 1 , the transformant being E. coli DH5α(pSTVDLP1, pBSDPS) (FERM BP-7548).

3. The transformant according to claim 1 , the transformant being E. coli DH5α(pSTVDLP1, pUhDPS1) (FERM BP-8025).

4. The transformant according to claim 1 , the transformant being E. coli DH5α(pSTVDLP1, pBmSDS1).

5. A method of producing coenzyme Q, comprising:

cultivating the transformant according to claim 1 in a medium to cause formation and accumulation of the coenzyme Q in the culture, and

recovering the coenzyme Q from the culture,

wherein a host microorganism of the transformant is capable of producing coenzyme Q.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →
Priority Claims (1)
JP 2001-140977 · May 11, 2001 · national
Continuity (2)
Division 10477269
Related Publication 20090130727A1 · May 21, 2009